Siga Technologies (SIGA) Other Accumulated Expenses (2019 - 2025)
Siga Technologies (SIGA) posted Other Accumulated Expenses of $869431.0 for Q4 2025, down 22.8% on a QoQ basis from $1.1 million in Q3 2025, and down 59.75% year-over-year from $2.2 million in Q4 2024.
Siga Technologies (SIGA) Other Accumulated Expenses (2019 - 2025) Analysis & Trends
Siga Technologies' Other Accumulated Expenses history runs 7 years deep, the most recent figure standing at $869431.0 for Q4 2025.
- Quarterly Other Accumulated Expenses fell 59.75% year-over-year to $869431.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $869431.0 (down 59.75% YoY) and the FY2025 annual result came in at $869431.0, down 59.75% from the prior year.
- Other Accumulated Expenses was $869431.0 for Q4 2025 at Siga Technologies, down from $1.1 million in the prior quarter.
- Across five years, Other Accumulated Expenses topped out at $2.3 million in Q1 2025 and bottomed at $278788.0 in Q2 2021.
- A 5-year average of $1.3 million and a median of $1.2 million in 2022 frame the typical range for Other Accumulated Expenses.
- Annual changes were most pronounced in 2021 — Other Accumulated Expenses slumped 70.15% — and 2022, when it jumped 235.29%.
- Siga Technologies' Other Accumulated Expenses stood at $1.4 million in 2021, then slipped by 10.4% to $1.3 million in 2022, then soared by 63.36% to $2.1 million in 2023, then advanced by 3.49% to $2.2 million in 2024, then plunged by 59.75% to $869431.0 in 2025.
- Business Quant data shows SIGA's Other Accumulated Expenses at $869431.0 in Q4 2025, $1.1 million in Q3 2025, and $1.2 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Siga Technologies | 225.56 Mn | 70.59 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 869,431.00 |
| Sep 30, 2025 | 1.13 Mn |
| Jun 30, 2025 | 1.16 Mn |
| Mar 31, 2025 | 2.29 Mn |
| Dec 31, 2024 | 2.16 Mn |
| Sep 30, 2024 | 2.23 Mn |
| Jun 30, 2024 | 2.19 Mn |
| Mar 31, 2024 | 2.10 Mn |
| Dec 31, 2023 | 2.09 Mn |
| Sep 30, 2023 | 1.07 Mn |
| Jun 30, 2023 | 1.33 Mn |
| Mar 31, 2023 | 1.34 Mn |
| Dec 31, 2022 | 1.28 Mn |
| Sep 30, 2022 | 852,370.00 |
| Jun 30, 2022 | 934,745.00 |
| Mar 31, 2022 | 753,540.00 |
| Dec 31, 2021 | 1.43 Mn |
| Sep 30, 2021 | 416,966.00 |
| Jun 30, 2021 | 278,788.00 |
| Mar 31, 2021 | 286,476.00 |